2017 Q2 Form 10-Q Financial Statement

#000156459017017270 Filed on August 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q4 2016 Q2
Revenue $18.74M $22.92M $25.75M
YoY Change -27.22% -21.02% -3.82%
Cost Of Revenue $8.207M $8.440M $8.894M
YoY Change -7.72% -10.12% -16.09%
Gross Profit $10.54M $14.48M $16.86M
YoY Change -37.51% -26.24% 4.22%
Gross Profit Margin 56.21% 63.18% 65.46%
Selling, General & Admin $10.66M $11.71M $14.30M
YoY Change -25.51% -15.51% -23.59%
% of Gross Profit 101.14% 80.87% 84.84%
Research & Development $6.646M $6.270M $7.044M
YoY Change -5.65% -13.04% -23.38%
% of Gross Profit 63.08% 43.3% 41.78%
Depreciation & Amortization $2.850M $2.960M $3.050M
YoY Change -6.56% -11.38% -2.56%
% of Gross Profit 27.05% 20.44% 18.09%
Operating Expenses $20.10M $18.47M $21.35M
YoY Change -5.85% -14.57% -23.52%
Operating Profit -$9.563M -$3.990M -$4.488M
YoY Change 113.08% 100.5% -61.76%
Interest Expense -$60.00K -$40.00K -$30.00K
YoY Change 100.0% 0.0% 200.0%
% of Operating Profit
Other Income/Expense, Net -$563.0K $370.0K $411.0K
YoY Change -236.98% 2.78% -350.61%
Pretax Income -$10.13M -$3.800M -$4.111M
YoY Change 146.31% 109.94% -65.48%
Income Tax $528.0K $790.0K $307.0K
% Of Pretax Income
Net Earnings -$10.55M -$4.600M -$4.418M
YoY Change 138.68% 114.95% -63.33%
Net Earnings / Revenue -56.26% -20.07% -17.16%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.871M -$831.8K -$808.0K
COMMON SHARES
Basic Shares Outstanding 38.64M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q4 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.50M $34.40M $35.40M
YoY Change -8.19% -7.77% -14.7%
Cash & Equivalents $33.82M $34.42M $35.40M
Short-Term Investments
Other Short-Term Assets $6.200M $5.100M $4.300M
YoY Change 44.19% 21.43% -34.85%
Inventory
Prepaid Expenses
Receivables $13.00M $18.76M $23.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $51.74M $58.28M $62.70M
YoY Change -17.48% -7.83% -8.33%
LONG-TERM ASSETS
Property, Plant & Equipment $17.74M $20.58M $21.10M
YoY Change -15.94% -5.67% 7.11%
Goodwill $16.68M $19.32M
YoY Change -0.51%
Intangibles $7.325M
YoY Change -29.6%
Long-Term Investments
YoY Change
Other Assets $1.587M $1.587M $1.700M
YoY Change -6.65% 19.95% 88.89%
Total Long-Term Assets $41.88M $48.81M $51.10M
YoY Change -18.05% -7.84% -2.11%
TOTAL ASSETS
Total Short-Term Assets $51.74M $58.28M $62.70M
Total Long-Term Assets $41.88M $48.81M $51.10M
Total Assets $93.62M $107.1M $113.8M
YoY Change -17.74% -7.83% -5.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.005M $2.434M $3.000M
YoY Change -33.17% 42.34% 42.86%
Accrued Expenses $6.400M $6.800M $8.600M
YoY Change -25.58% -28.42% -22.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.100M $1.000M $800.0K
YoY Change 37.5% -28.57% -57.89%
Total Short-Term Liabilities $12.12M $12.61M $15.20M
YoY Change -20.3% -19.75% -15.56%
LONG-TERM LIABILITIES
Long-Term Debt $2.000M $2.400M $1.500M
YoY Change 33.33% 50.0%
Other Long-Term Liabilities $4.493M $4.508M $4.500M
YoY Change -0.16% -5.99% -2.17%
Total Long-Term Liabilities $4.493M $4.508M $6.000M
YoY Change -25.12% -5.99% 30.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.12M $12.61M $15.20M
Total Long-Term Liabilities $4.493M $4.508M $6.000M
Total Liabilities $18.59M $19.50M $21.20M
YoY Change -12.3% -11.63% -6.19%
SHAREHOLDERS EQUITY
Retained Earnings -$212.9M -$196.2M
YoY Change 9.17%
Common Stock $289.5M $286.7M
YoY Change 4.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $75.02M $87.60M $92.60M
YoY Change
Total Liabilities & Shareholders Equity $93.62M $107.1M $113.8M
YoY Change -17.74% -7.83% -5.67%

Cashflow Statement

Concept 2017 Q2 2016 Q4 2016 Q2
OPERATING ACTIVITIES
Net Income -$10.55M -$4.600M -$4.418M
YoY Change 138.68% 114.95% -63.33%
Depreciation, Depletion And Amortization $2.850M $2.960M $3.050M
YoY Change -6.56% -11.38% -2.56%
Cash From Operating Activities -$470.0K $1.280M $1.540M
YoY Change -130.52% -80.37% -125.8%
INVESTING ACTIVITIES
Capital Expenditures -$510.0K -$720.0K -$1.760M
YoY Change -71.02% -60.66% -62.63%
Acquisitions
YoY Change
Other Investing Activities $10.00K $0.00
YoY Change -104.35%
Cash From Investing Activities -$510.0K -$710.0K -$1.750M
YoY Change -70.86% -65.53% -62.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -470.0K -470.0K -270.0K
YoY Change 74.07% 42.42% -70.97%
NET CHANGE
Cash From Operating Activities -470.0K 1.280M 1.540M
Cash From Investing Activities -510.0K -710.0K -1.750M
Cash From Financing Activities -470.0K -470.0K -270.0K
Net Change In Cash -1.450M 100.0K -480.0K
YoY Change 202.08% -97.58% -95.87%
FREE CASH FLOW
Cash From Operating Activities -$470.0K $1.280M $1.540M
Capital Expenditures -$510.0K -$720.0K -$1.760M
Free Cash Flow $40.00K $2.000M $3.300M
YoY Change -98.79% -76.05% -361.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2017Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2797000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
20098000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9426000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
us-gaap Depreciation
Depreciation
2599000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1655000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1451000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-512000
us-gaap Paid In Kind Interest
PaidInKindInterest
13000
us-gaap Share Based Compensation
ShareBasedCompensation
2760000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
785000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
101000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0
mrin Payment Of Contingent Consideration For Prior Acquisition
PaymentOfContingentConsiderationForPriorAcquisition
93000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1323000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
341000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1275000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3945000
us-gaap Cost Of Revenue
CostOfRevenue
18084000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4508000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
795000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
289415000
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1015000
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38787000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
39000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2381000
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4914000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
58282000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12606000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
40000
us-gaap Revenues
Revenues
52941000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
286659000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-212884000
CY2016Q4 us-gaap Liabilities
Liabilities
19495000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39542000
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39542000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1549000
us-gaap Revenues
Revenues
39075000
us-gaap Cost Of Revenue
CostOfRevenue
16531000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
107093000
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196213000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
75022000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2887000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
87598000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93615000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20581000
CY2016Q4 us-gaap Goodwill
Goodwill
19318000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18761000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3808000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17737000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1293000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1293000
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5874000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
21347000
us-gaap Operating Expenses
OperatingExpenses
38089000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9563000
us-gaap Operating Expenses
OperatingExpenses
43432000
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
8207000
CY2017Q2 us-gaap Revenues
Revenues
18742000
CY2016Q2 us-gaap Revenues
Revenues
25753000
CY2016Q2 us-gaap Gross Profit
GrossProfit
16859000
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
8894000
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6710000
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9285000
CY2017Q2 us-gaap Gross Profit
GrossProfit
10535000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7044000
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
676000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13001000
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1081000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
51737000
CY2017Q2 us-gaap Goodwill
Goodwill
16680000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12115000
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1985000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4493000
CY2017Q2 us-gaap Liabilities
Liabilities
18593000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6646000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38792000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7325000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1587000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1587000
CY2017Q2 us-gaap Assets
Assets
93615000
CY2016Q4 us-gaap Assets
Assets
107093000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2005000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2434000
CY2017Q2 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
8353000
CY2016Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
8362000
CY2017Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-64000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-101000
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-499000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10126000
us-gaap Operating Income Loss
OperatingIncomeLoss
-8575000
CY2016Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-34000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
411000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4488000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15545000
us-gaap Net Income Loss
NetIncomeLoss
-8831000
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1119000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-324000
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15333000
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8730000
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39478000
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38280000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2797000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-4418000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Gross Profit
GrossProfit
22544000
us-gaap Gross Profit
GrossProfit
34857000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13386000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18392000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13784000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15053000
us-gaap Net Income Loss
NetIncomeLoss
-16671000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5018000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8122000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9987000
CY2016Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39006000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-52000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-200000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
444000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4111000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15846000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
307000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
648000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
101000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38023000
us-gaap Depreciation
Depreciation
3207000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1620000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
344000
us-gaap Paid In Kind Interest
PaidInKindInterest
13000
us-gaap Share Based Compensation
ShareBasedCompensation
6761000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
368000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8183000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
419000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
825000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-10545000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4742000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1338000
mrin Payment Of Contingent Consideration For Prior Acquisition
PaymentOfContingentConsiderationForPriorAcquisition
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4846000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-412000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1155000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
13000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-459000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-126000
mrin Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
-520000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1426000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
260000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
956000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1214000
mrin Effect Of Exchange Rate On Cash And Cash Equivalents And Restricted Cash Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsAndRestrictedCashContinuingOperations
1161000
CY2015Q4 mrin Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
37326000
CY2017Q2 mrin Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
33822000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
181000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20000
mrin Noncash Or Part Noncash Acquisition Employee Stock Purchase Plan Shares Issued Value
NoncashOrPartNoncashAcquisitionEmployeeStockPurchasePlanSharesIssuedValue
130000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
189000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
430000
mrin Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
-1224000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2137000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
111000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-523000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-334000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
617000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2900000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3514000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-989000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-370000
mrin Effect Of Exchange Rate On Cash And Cash Equivalents And Restricted Cash Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsAndRestrictedCashContinuingOperations
-137000
mrin Cash And Cash Equivalents And Restricted Cash Period Increase Decrease
CashAndCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
-1891000
mrin Cash And Cash Equivalents And Restricted Cash Period Increase Decrease
CashAndCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
-1884000
CY2016Q4 mrin Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
35713000
CY2016Q2 mrin Cash And Cash Equivalents And Restricted Cash At Carrying Value
CashAndCashEquivalentsAndRestrictedCashAtCarryingValue
35442000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
339000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
24000
mrin Noncash Or Part Noncash Acquisition Employee Stock Purchase Plan Shares Issued Value
NoncashOrPartNoncashAcquisitionEmployeeStockPurchasePlanSharesIssuedValue
328000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2006-03-31
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y11M23D
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Out-of-Period Adjustment</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">In the second quarter of 2017, the Company recorded an out-of-period adjustment to correct previously overstated revenues related to our display product offering. This adjustment has accumulated since our acquisition in June 2014 of NowSpots, Inc. (d.b.a. Perfect Audience), resulting in a decrease to revenues in the amount of $400 for the three months ended June 30, 2017. The Company determined that this adjustment was not material to its prior period consolidated financial statements and is not expected to be material to its condensed consolidated financial statements for the current year.</p></div>
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3389000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3510000
CY2017Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1082000
CY2016Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1947000
CY2017Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
2797000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
2797000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017Q2 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
400000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58227000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57125000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
40490000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36544000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4254000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4607000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3376000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3894000
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2057000
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1915000
CY2017Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1998000
CY2016Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1582000
CY2017Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
139000
CY2016Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
210000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
783000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
761000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
159000
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14670000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14670000
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8796000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7345000
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
721000
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
794000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1399000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2537000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1843000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
95000
CY2016Q2 us-gaap Restructuring Costs
RestructuringCosts
425000
us-gaap Restructuring Costs
RestructuringCosts
425000
CY2017Q2 us-gaap Restructuring Costs
RestructuringCosts
0
us-gaap Restructuring Costs
RestructuringCosts
0
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
623000
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
1117000
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
928000
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
389000
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
11000
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3068000
CY2017Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2000
CY2017Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
15855000
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14281000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3749000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
979000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3270000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2182000
CY2017Q2 mrin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber
2180000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3182000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.26
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.24
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.76
CY2017Q2 mrin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedPeriodWeightedAverageExercisePrice
6.76
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.65
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M23D
mrin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2Granted
P9Y9M25D
mrin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term Two Forfeited Or Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermTwoForfeitedOrCancelled
P0Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.475
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0144
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M30D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M1D
mrin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm
P5Y11M1D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y11M1D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
194000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
28000
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
28000
CY2017Q2 mrin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue
28000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
28000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3003000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
551000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
181000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
814000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2559000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.37
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3.05
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.70
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
918000
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2939000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.473
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.476
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.473
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0203
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0134
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0203
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M30D
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M30D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M30D
CY2017Q2 mrin Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.070
CY2016Q2 mrin Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.070
mrin Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.070
mrin Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.070
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1442000
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2017Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2016Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5829000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8329000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5829000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8329000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2188000
CY2016Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2385000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4268000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4553000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2695000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3504000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4063000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3361000
CY2017Q2 mrin Operating Leases Future Minimum Payments Due In Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter
6070000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
19693000
CY2016Q4 us-gaap Litigation Reserve
LitigationReserve
0
CY2017Q2 us-gaap Litigation Reserve
LitigationReserve
0

Files In Submission

Name View Source Status
0001564590-17-017270-index-headers.html Edgar Link pending
0001564590-17-017270-index.html Edgar Link pending
0001564590-17-017270.txt Edgar Link pending
0001564590-17-017270-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201708100126449173863.jpg Edgar Link pending
mrin-10q_20170630.htm Edgar Link pending
mrin-20170630.xml Edgar Link completed
mrin-20170630.xsd Edgar Link pending
mrin-20170630_cal.xml Edgar Link unprocessable
mrin-20170630_def.xml Edgar Link unprocessable
mrin-20170630_lab.xml Edgar Link unprocessable
mrin-20170630_pre.xml Edgar Link unprocessable
mrin-ex101_96.htm Edgar Link pending
mrin-ex311_8.htm Edgar Link pending
mrin-ex312_6.htm Edgar Link pending
mrin-ex321_9.htm Edgar Link pending
mrin-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending